PAHC Stock Analysis
PA
Avoid
Based on Eyestock quantitative analysis, PAHC`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,860 full-time employees. The company went IPO on 2014-04-11. The firm develops and markets a range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. The firm operates through three segments, which include Animal Health, Mineral Nutrition and Performance Products. Its Animal health segment includes products, such as antibacterial, anticoccidials, nutritional specialty products and vaccines. This segment also includes antibacterial and other processing aids used in the ethanol fermentation industry. Its Mineral Nutrition segment manufactures and markets approximately 400 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds. Its Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, primarily in the United States.